Unicorn Currencies
Login
Unicorn Currencies
HOME

COMPANY

Why Unicorn CurrenciesWho it is forTrustComplianceCanada

MONEY MOVEMENT

How it worksPay-InFXPay-OutPricing

CAPABILITY

PlatformIndustriesCompare

SUPPORT

FAQContact
Login→
Industry payment profile

Pharmaceutical & Medical Supplies payment problems need FX, proof, and timing control.

Pharmaceutical & Medical Supplies businesses can face international payment pressure when supplier timing, FX exposure, document review, deductions, or reconciliation issues affect commercial operations.

Unicorn Currencies is built for businesses with £1M+ equivalent annual FX exposure and recurring international supplier, customer, or treasury payment flows.

Pharmaceutical & Medical Supplies payment pressure map

  1. 1Supplier timingDeposits, balances, shipment release, production deadlines, or supplier pressure.
  2. 2FX exposureCurrency movement, landed cost, supplier pricing, and margin impact.
  3. 3Document and review riskInvoices, contracts, beneficiary questions, compliance review, or trade evidence.
  4. 4Cash and reconciliationFunds tied before release, short-paid wires, references, invoice matching, and finance records.

The pressure is not only moving money. It is proving, timing, and reconciling the payment.

Why this industry feels payment pressure

Pharmaceutical & Medical Supplies teams manage Payment upon batch release approval (not shipment). LC for first orders. Net 45-60 for established Indian generics suppliers.. Import pharmaceuticals, medical devices, and healthcare supplies Payment pressure often appears when FX exposure, document review, or reconciliation gaps affect commercial operations—especially where regulatory holds at border or batch testing delays payments slows finance and supplier confidence.

Common payment problems in this industry

Delayed supplier payment

When a pharmaceutical & medical supplies supplier payment is delayed, Payment upon batch release approval (not shipment). LC for first orders. Net 45-60 for established Indian generics suppliers. can collide with shipment release, production schedules, or balance-payment deadlines.

Read delayed supplier payment →

FX margin leak

FX pressure for pharmaceutical & medical supplies often follows MODERATE: INR (generics), CHF (branded), EUR (devices). High margins (40-60%) on branded provide FX buffer. Generics (15-25%) more FX-sensitive. Landed cost and margin are harder to defend when payment economics are unclear.

Read fx margin leak →

Document hold

Payments may pause when banks request Certificate of Analysis (CoA) or Certificate of Pharmaceutical Product (CPP)—or other trade evidence—before crediting the beneficiary.

Read document hold →

Cash tied before release

Working capital can sit tied before release when Steady with flu season spikes (Oct-Mar). NHS contract cycles. Pandemic/epidemic surges unpredictable. Clinical trial timelines project-based. and uncertain payment timing overlap.

Read cash tied before release →

What finance teams should check

  • Payment purpose
  • Supplier or customer country
  • Currency pair
  • Invoice or contract
  • Expected payment date
  • Route and timing factors
  • Final received amount
  • Payment proof available
  • Reconciliation record
  • Compliance or document review context

Where Unicorn Currencies fits

Unicorn Currencies is best suited to businesses with £1M+ equivalent annual FX exposure, recurring international payment flows, and a need for FX visibility, payment proof, reconciliation clarity, and human treasury support.

Payment timelines depend on currency, route, provider approval, jurisdiction, beneficiary bank, compliance review, and banking cut-off times.

Not built for

  • One-off personal transfers
  • Retail remittance
  • Domestic-only banking
  • Speculative FX trading
  • Occasional small conversions

Related pages

IndustriesPayment ProblemsPay-InForeign ExchangePay-OutPlatformPricingTrustCompliance
Talk to TreasuryTrust
LegalApplyCurrenciesCountriesDemurrage CalculatorMulti-Currency AccountPayment Problems

Unicorn Currencies Limited is registered with FINTRAC as a Money Services Business and registered with the Bank of Canada as a Payment Service Provider under the Retail Payment Activities Act. UK services are provided by Unicorn Currencies Ltd as a corporate intermediary through authorised partners where regulated payment or e-money services are required. Legal and regulatory information.